0026

Valiant Co.,Ltd Stock Price

SZSE:002643 Community·CN¥12.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002643 Share Price Performance

CN¥13.75
2.34 (20.51%)
CN¥13.75
2.34 (20.51%)
Price CN¥13.75

002643 Community Narratives

There are no narratives available yet.

Recent 002643 News & Updates

Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its Earnings

Mar 25
Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its Earnings

Valiant Co.,Ltd Key Details

CN¥3.6b

Revenue

CN¥2.3b

Cost of Revenue

CN¥1.3b

Gross Profit

CN¥1.1b

Other Expenses

CN¥249.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 27, 2025
Earnings per share (EPS)
0.27
Gross Margin
36.08%
Net Profit Margin
6.91%
Debt/Equity Ratio
21.9%

Valiant Co.,Ltd Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

2 Risks
1 Reward

About 002643

Founded
1992
Employees
4733
CEO
Zhong Li Wang
WebsiteView website
www.valiant-cn.com

Valiant Co.,Ltd. research, develops, produces and sells chemical materials worldwide. The company provides LCD, OLED, cyclohexane materials, photoresist monomer, PAG, polymers, specialty chemicals, and polyimide monomer; and environmental protection materials, including automobile exhausts purification materials, flue gas denitrification, VOCs adsorption, methanol to olefin, petroleum cracking materials, new energy materials, energy-saving lighting materials, organic solar technology, other supporting materials for new energy vehicles, etc. It also offers electrolyte additives for lithium batteries and perovskite solar cell materials. In addition, the company offers API, pharmaceutical intermediates, pharmaceutical formulations, Chinese medicine, and nutrition and health foods; life science products related to drug development, genomics, proteomics, metabonomics, food safety analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, fever, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse, endocrine levels, and other human conditions. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. As for the past 12 months, the market is up 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›